Protein C Test: The Brake on Clotting That Warfarin Removes First
When a low protein C result can be trusted, how warfarin and a recent clot lower it, how much deficiency raises clot risk, and who current guidelines say should be tested.
- Reference range
-
70–150 % Adult Male70–150 % Adult Female
- LOINC code
-
27818-4
on loinc.org
Universal lab test identifier
- Also reported as
- Autoprothrombin II-a
Part of the Coagulation Panel — see all 12 values together, including Antithrombin III, Factor V Leiden, Factor VIII.
Protein C is one of the body's own anticoagulants. The liver makes it, and once switched on it shuts down two clotting factors so a clot stays where it is needed. The test measures protein C activity in a blood sample, as a percentage of normal. A low result means less of that natural control and a higher risk of clots; a high result is not known to cause health problems.
Most people meet this test after a blood clot: a deep vein thrombosis or pulmonary embolism before age 50 with no clear trigger, a clot in an unusual place such as the veins of the liver, kidney or brain, repeated clots, or a close relative with a known deficiency.
Most adult labs put the normal range at about 70 to 150 percent; Labcorp starts its range at 77. But the number on a single report is less important than when the blood was drawn, because the two situations in which people are most often tested, during treatment for a clot and soon after one, are exactly the ones in which protein C reads low for reasons that have nothing to do with inheritance.
When a protein C result can be trusted
Warfarin lowers protein C. It blocks all the vitamin K–dependent proteins, and protein C is one of them, so anyone taking warfarin will have a low result whether or not they have a deficiency. Labcorp reports that protein C starts falling about six hours after the first dose and generally does not return to baseline until about two weeks after warfarin is stopped. An active or recent clot lowers it too, because protein C is used up while clotting is under way. MedlinePlus advises waiting until a person has recovered from a clot before testing.
A result of 52 percent drawn three weeks after a leg clot, on warfarin, tells you nothing about whether the deficiency is inherited. The same 52 percent on a sample taken well after recovery, two weeks off warfarin, is a different matter. Whether and when to pause an anticoagulant is the prescriber's decision. Labcorp's shorter washouts are about three days for heparin and the newer direct blood thinners.
The timing also explains a well-known warfarin precaution. Protein C has a half-life of about 8 hours, against about 60 hours for prothrombin (factor II), according to the warfarin prescribing information. In the first days of treatment the natural brake falls faster than the clotting factors, so the blood can briefly lean toward clotting.
That is why heparin is usually given alongside warfarin for the first 5 to 7 days, and why rare tissue necrosis, usually in the skin, at the start of warfarin has been linked to protein C or S deficiency. The prothrombin time and INR used to dose warfarin track the clotting factors, not protein C.
What a low protein C means
Reading a protein C activity result
%Expected in these circumstances. The test is repeated on a better-timed sample.
People with one altered gene often sit near the bottom of the range, so a borderline value is repeated before anything is concluded.
Confirmed with a repeat and often a protein C antigen test, sometimes with genetic testing.
Nothing further to investigate from this result.
Acquired causes are more common than the inherited one, and clinicians rule them out first:
Common reasons for a low protein C other than inheritance
-
Warfarin and other vitamin K antagonists
-
A current or recent blood clot
-
Liver disease
The liver makes protein C.
-
Vitamin K deficiency
-
Severe infection or disseminated intravascular coagulation
Widespread clotting uses protein C faster than it can be replaced.
-
Kidney disease, cancer or chemotherapy
-
Pregnancy or estrogen-containing contraception
The inherited form comes from a change in the PROC gene. One altered copy is enough to cause mild deficiency, which MedlinePlus Genetics estimates affects about 1 in 500 people; many of them never have a clot. Two altered copies cause severe deficiency in newborns, about 1 in 4 million births. Separating the two forms usually takes a repeat test off anticoagulation and away from the clot, a protein C antigen test to see whether there is too little protein or protein that works poorly, and sometimes PROC gene testing.
How much the risk actually changes
The American Society of Hematology (ASH) 2023 thrombophilia guideline puts protein C deficiency in a median of 2.5 percent of people who present with a venous clot. In relatives of a known carrier it raises the chance of a first clot about sevenfold. In someone who has already had a clot, it roughly doubles the chance of another, a smaller effect than the word "deficiency" suggests.
Is testing worth it after a clot?
Often not, according to the same guideline. It suggests against protein C testing after an unprovoked clot, because long-term anticoagulation is usually recommended anyway and a positive result would not change that plan. Its one strong recommendation is also against testing: women considering combined oral contraceptives should not be screened for thrombophilia as a group.
ASH does suggest testing in narrower situations: a clot provoked by pregnancy, the weeks after birth, combined oral contraceptives or another temporary non-surgical risk; a clot in the veins of the brain or abdominal organs when anticoagulation might otherwise stop; and relatives of someone with a known protein C, protein S or antithrombin deficiency who are weighing preventive treatment or estrogen.
Which assay was used
Protein C activity is measured in two ways. Labcorp's test is chromogenic: an enzyme switches protein C on and the result is read from a colour change. Clot-based versions time a reaction similar to the aPTT and can read falsely low in people who carry factor V Leiden or have a high factor VIII, as happens during inflammation. A low result from a clot-based assay is worth checking against the method.
Protein C deficiency itself causes no symptoms. What people notice is a clot: swelling, pain, warmth or redness in one leg, or sudden breathlessness, chest pain or coughing blood when a clot reaches the lungs. The NHLBI lists these as reasons for urgent care, whatever any lab result says.
Sources
- MedlinePlus: Protein C and Protein S Tests
- MedlinePlus Genetics: Protein C deficiency
- Labcorp: Protein C, Functional (test 117705)
- DailyMed (NLM): Warfarin Sodium tablet prescribing information
- American Society of Hematology: Clinical Practice Guidelines on Venous Thromboembolism
- NHLBI: Venous Thromboembolism
Written and reviewed by BloodSight Editorial Team · Last updated
See your Protein C on one timeline.
BloodSight keeps each lab's own reference range next to every value — and shows every result across every visit.
Within the lab's reference range
Normal ranges
| Group | Range | Unit |
|---|---|---|
| Adult Male | 70–150 | % |
| Adult Female | 70–150 | % |
Reference ranges may vary by laboratory and individual factors.
Protein C — Common Questions
Is a protein C level of 60% low?
Why does my doctor want me off warfarin before a protein C test?
Can an active blood clot make protein C look falsely low?
Is low protein C always inherited?
Should I be tested for protein C deficiency after a blood clot?
Does protein C deficiency cause symptoms you can feel?
Does a high protein C result mean anything?
Disclaimer
This content is for informational and educational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Reference ranges may vary by laboratory. Always discuss your results with a qualified healthcare professional.
Related Tests
Most coagulation tests flag blood that clots too slowly. Antithrombin flags the opposite problem, and how far it falls matters far more than whether it falls at all.
What one copy versus two means in absolute numbers, when the extra clot risk matters, how the DNA and clotting tests differ, and why testing after a clot rarely changes treatment.
A prothrombin time is the first clotting screen to move when the liver falls behind or vitamin K runs short, and one of the easiest to prolong by accident at the blood draw itself.
INR is the one lab number where the goal can be a result that looks abnormal. A healthy untreated person sits near 1.0; someone on warfarin is steered toward 2.0–3.0 on purpose.
D-dimer is the fragment left when the body dismantles a clot. It is the rare test you hope reads negative, because that is the only answer it gives with real confidence.